Clinical Trial Update: Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating transcranial static magnetic field stimulation to prevent levodopa-induced dyskinesias in Parkinson's disease patients has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyskinesia Medication-induced
• Parkinson Disease

Snippet

Sponsor: Fundación de investigación HM | Conditions: Dyskinesia, Medication-Induced, Parkinson's Disease | Phase 2 | Status: COMPLETED